Modulatory Potential of Iron Chelation Therapy on Nitric Oxide Formation in Cerebral Malaria
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
To determine whether iron chelation modulates nitric oxide (NO) formation and cell-mediated immune effector function in children with cerebral malaria, serum concentrations were measured of the stable end products of NO, nitrite and nitrate (NO2-/NO3-), interleukin (IL)-4, -6, and -10, and neopterin in 39 Zambian children enrolled in a placebo-controlled trial of desferrioxamine B and quinine therapy. Mean concentrations of NO2-/NO3- increased significantly over 3 days in children receiving desferrioxamine plus quinine but not in those given placebo and quinine. Neopterin levels declined significantly with placebo but not with desferrioxamine. IL-4 levels increased progressively in the placebo group and ultimately decreased in the desferrioxamine group, but the trends were not statistically significant. IL-6 and IL-10 levels were elevated initially and decreased significantly in both groups over 3 days. These data are consistent with the hypothesis that iron chelation therapy in children with cerebral malaria strengthens Th1-mediated immune effector function involving increased production of NO.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hibbs, J. B., Westenfelder, C., Taintor, R., Vavrin, Z., Kablitz, C., Baranowski, R. L., Ward, J. H., Menlove, R. L., McMurry, M. P., & Kushner, J. P. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115666 · Cited by 485
Iron regulates nitric oxide synthase activity by controlling nuclear transcription.
Weiss, G., Werner-Felmayer, G., Werner, E. R., Grünewald, K., Wachter, H., & Hentze, M. W. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.969 · Cited by 412
Self-citationEffect of Iron Chelation Therapy on Recovery from Deep Coma in Children with Cerebral Malaria
Gordeuk, V., Thuma, P., Brittenham, G., McLaren, C., Parry, D., Backenstose, A., Biemba, G., Msiska, R., Holmes, L., McKinley, E., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211193272101 · Cited by 210 · cited 3×
“Patients were selected for the study as previously described [5].”
BackgroundMethodSelf-citationLinkage of cell-mediated immunity to iron metabolism
Weiss, G., Wachter, H., & Fuchs, D. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80034-4 · Cited by 200
Self-citationThuma, P. E., Weiss, G., Herold, M., & Gordeuk, V. R. (1996) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1996.54.164 · Cited by 29
Cited by
Newton, C. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00008-4 · Cited by 348
Iron at the interface of immunity and infection
Nairz, M., Haschka, D., Demetz, E., & Weiss, G. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00152 · Cited by 325
Self-citationIron metabolism in the anemia of chronic disease
Weiss, G. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.08.006 · Cited by 322
Self-citationIron and immunity: a double-edged sword.
Weiss, G. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.0320s1070.x · Cited by 317
Self-citationPolarization dictates iron handling by inflammatory and alternatively activated macrophages
Corna, G., Campana, L., Pignatti, E., Castiglioni, A., Tagliafico, E., Bosurgi, L., Campanella, A., Brunelli, S., Manfredi, A. A., Apostoli, P., et al. (2010) · Haematologica · doi:10.3324/haematol.2010.023879 · Cited by 304
Pathogenesis and treatment of anaemia of chronic disease
Weiss, G. (2002) · Blood Reviews · doi:10.1054/blre.2002.0193 · Cited by 277
Self-citationIron Deficiency Protects Against Severe Plasmodium falciparum Malaria and Death in Young Children
Gwamaka, M., Kurtis, J. D., Sorensen, B. E., Holte, S., Morrison, R., Mutabingwa, T. K., Fried, M., & Duffy, P. E. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis010 · Cited by 197
Modification of iron regulation by the inflammatory response
WEISS, G. (2005) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2004.09.001 · Cited by 161
Self-citationIron Chelation Therapy for Malaria
Mabeza, G. F., Loyevsky, M., Gordeuk, V. R., & Weiss, G. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00037-0 · Cited by 111
“In one study, serum levels of neopterin did not change significantly in children receiving DFO plus quinine, but did decline significantly in children receiving placebo plus quinine (Weiss et al., 1997).”
BackgroundInfluentialSelf-citationFritsche, G., Larcher, C., Schennach, H., & Weiss, G. (2001) · The Journal of Infectious Diseases · doi:10.1086/319860 · Cited by 84
“This was of interest because of in vitro data showing that iron inhibits the formation of NO by a transcriptional mechanism [17], which leads to reduced binding of NF-IL6 to the iNOS promoter [18], and because of in vivo data showing increased serum nitrite and nitrate levels in children receiving DFO in addition to s…”
BackgroundMethodSelf-citationTheurl, I., Fritsche, G., Ludwiczek, S., Garimorth, K., Bellmann-Weiler, R., & Weiss, G. (2005) · BioMetals · doi:10.1007/s10534-005-3710-1 · Cited by 72
Self-citation
Metadata
- Authors
- Weiss, G., Thuma, P. E., Mabeza, G., Werner, E. R., Herold, M., & Gordeuk, V. R.
- Venue
- Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1997-01-01
- Volume
- 175
- Issue
- 1
- Pages
- 226-230
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2047097834
- Cited by
- 52
- References
- 5
- FWCI
- 7.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.